应用CiteSpace软件对高血压合并勃起功能障碍相关研究的可视化分析  

Visual analysis of researches related to hypertension complicated with erectile dysfunction using CiteSpace software

作　　者：王继升[1] 王显[2] 李海松[1] 邓省 李海燕[2] 李祎铭 WANG Jisheng;WANG Xian;LI Haisong;DENG Sheng;LI Haiyan;LI Yiming(Department of Andrology,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing100700,China;Department of Cardiovascular Medicine,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing100700,China)

机构地区：[1]北京中医药大学东直门医院男科,北京100700 [2]北京中医药大学东直门医院心血管内科,北京100700

出　　处：《中国医药导报》2022年第19期90-93,共4页China Medical Herald

基　　金：国家自然科学基金资助项目(81774320)。

摘　　要：目的 分析高血压合并勃起功能障碍的国内研究现状。方法 以中国知网数据库为数据来源,利用CiteSpace软件对1990年1月至2021年8月的30余年中高血压与勃起功能障碍的相关研究进行可视化分析,探讨相关研究的作者、机构分布状况及对关键词进行分析。结果 纳入中文文献144篇,年发文量呈现波动上升的趋势;核心作者已经形成若干较稳定的研究团队,但团队之间合作并不紧密;关键词分析发现涉及临床试验、基础实验、名医经验等多维度、多层次的研究类型。结论 本研究对现阶段高血压与勃起功能障碍关系的研究进展提供了立体化的总结,为研究者提供了潜在的有价值信息。Objective To analyze the domestic research status of hypertension complicated with erectile dysfunction.Methods Using CNKI database as the data source, the CiteSpace software was used to visualize and analyze the related researches on hypertension and erectile dysfunction in the period of more than 30 years from January 1990 to August2021. The authors of relevant studies, the distribution of institutions were explored, and keywords were analyzed. Results A total of 144 Chinese literatures were included, and the annual publication volume was showed a trend of rising fluctuations;the core authors had formed a number of relatively stable research teams, but the cooperation between the teams was not close;keyword analysis found that there were multi-dimensional and multi-level research types involving clinical trials, basic experiments, and famous doctors’ experience. Conclusion This study provides a three-dimensional summary of the current research progress on the relationship between hypertension and erectile dysfunction, and provides potentially valuable information for researchers.

关 键 词：CITESPACE 高血压 勃起功能障碍 可视化分析 

分 类 号：R54[医药卫生—心血管疾病]